Selected Aspects of Medical Care for Patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD) in Poland

Abstract

Introduction: Noncompliance with healthcare undoubtedly has a strong influence on the high prevalence of uncontrolled obstructive diseases. The aim of our study was to evaluate the quality of medical conduct in patients with asthma or chronic obstructive lung diseases (COPD), with encompassed two-levelled system of health care. Material and methods: A survey of general practitioners (GP), allergists and pulmonologists practicing in Poland was performed between September and December 2016. The basic survey included the data concerning the number of treated patients, the course of the visits, treatment regimens and whether the patients follow the instructions of the physician. The specialist survey recorded the details of the specialist visits, their frequency and character, an evaluation of the pharmacological and non-pharmacological therapies and an evaluation of the GP's actions. Results: The basic questionnaire was completed by 807 doctors with an average of 21 ± 9.85 years of medical experience. Most of the interviewed individuals were GPs (56%), followed by pulmonologists (28%) and allergists (16%). The GP reported 47 cases/month with obstructive pulmonary conditions, including 48.94% asthma and 51.06% COPD patients. They diagnosed three new asthma and COPD patients per month. The allergists treated patients with asthma (105 patients/ /month), with 19 newly-diagnosed patients/month. The pulmonologists treated fewer asthma cases than COPD: 71 and 98 patients respectively. They reported 14 patients/month of newly-diagnosed COPD cases. The patients took inhaled glucocorticoids and long-acting b adrenoceptor agonists in separate inhalers. The most frequently-used device was a disc. In opinion of the specialists, half of the therapies initiated recently by GPs for patients with asthma and COPD required modifications. Conclusions: There is a disparity between the true state of medical care of asthma and COPD patients and globally-accepted standards.

CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling

“…COPD is a disease characterized by airflow limitation, which is strongly associated with increased chronic inflammatory responses to noxious particles or gases (mainly tobacco smoke) in the airways and lungs. Recently, several studies have shown that pulmonary hypertension and pulmonary vascular remodeling are the most important and critical links in the development of COPD in patients with pulmonary heart disease [ 5 , 34 , 35 ]. Therefore, controlling pulmonary vascular remodeling and pulmonary hypertension induced by COPD is important for delaying its cardiovascular complications.…”

Inhaled Glucocorticoid with or without Tiotropium Bromide for Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome

“…Patients having bronchial obstruction due to inflammation in the airways, often present with clinical symptoms such as dyspnea, respiratory restriction, and cough. 1,2 Related studies have shown that there are certain overlaps in the pathogenesis, clinical symptoms, and predisposing factors of asthma and chronic obstructive pulmonary disease. 3 This overlap is referred to as asthma-chronic obstructive pulmonary overlap syndrome (ACOS).…”

Quality of life of patients with chronic obstructive pulmonary disease treated with indacaterol and/or glycopyrronium: a real-world Polish observational study

“…Specialists declared that half of the treatments recommended recently by general practitioners required modifications. The medications were administered via a separate inhaler in most cases [10]. Delayed access to medicines limited their implementation in clinical practice.…”